Quantcast
Last updated on May 18, 2013 at 5:08 EDT

Latest Drug Addiction Treatment Act Stories

2013-05-08 16:27:10

DALLAS, May 8, 2013 /PRNewswire/ -- Michael Cannizzaro, Behavioral Health Group (BHG) Chairman and Chief Executive Officer, announced that BHG treatment centers are now offering both Buprenorphine and Methadone in their medication-assisted treatment programs. Mr. Cannizzaro said, "BHG's outpatient opioid addiction treatment centers address each patient's physical opioid addiction with either Methadone or Buprenorphine medications in combination with counseling and skill...

2012-09-25 06:27:08

RICHMOND, Va., Sept. 25, 2012 /PRNewswire/ - Reckitt Benckiser Pharmaceuticals Inc. issued a Citizen Petition today to request the U.S. Food and Drug Administration (FDA) to require all manufacturers of buprenorphine-containing products for the treatment of opioid dependence to implement national public health safeguards involving pediatric exposure educational campaigns and child resistant, unit-dosed packaging to reduce the risk of pediatric exposure. The company has had in...

2011-03-29 06:50:00

FARMINGTON, Conn., March 29, 2011 /PRNewswire/ -- The National Alliance of Advocates for Buprenorphine Treatment (www.NAABT.org) is proud to report a milestone with its free www.TreatmentMatch.org service. This month the 40,000th patient reached out for help with the system. www.TreatmentMatch.org functions similar to online dating services but instead it connects patients looking for lifesaving modern addiction treatment with one or several of the few providers who are able to prescribe...

2011-03-14 20:52:24

Researchers from Boston University School of Medicine (BUSM) have found that for the majority of patients with opioid addiction, collaborative care with nurse care managers is a successful method of service delivery while effectively utilizing the time of physicians prescribing buprenorphine. The findings, which appear in the March 14 issue of the Archives of Internal Medicine, serve as a model of service delivery for facilitating access and improving outcomes in patients with opioid...

2010-06-04 11:00:00

Seasoned Executive Brings Diverse Leadership Experience to Specialty Society CHEVY CHASE, Md., June 4 /PRNewswire-USNewswire/ -- Penny S. Mills, a seasoned executive with extensive association management, consulting, health policy and health system experience, has been selected as the new Executive Vice President (EVP) of the American Society of Addiction Medicine (ASAM). Ms. Mills will start in the new position July 1, following the retirement of long-time EVP Eileen McGrath. ASAM is the...

2010-03-30 17:00:00

SOUTH SAN FRANCISCO, Calif., March 30 /PRNewswire-FirstCall/ -- Titan Pharmaceuticals, Inc. (Pink Sheets: TTNP) today announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction. This confirmatory Phase 3 study will be conducted at approximately 23 sites in the United States and randomize approximately 250 patients into three arms: Probuphine (100 patients), Suboxone® (100 patients) and...

2009-08-17 16:30:00

CHEVY CHASE, Md., Aug. 17 /PRNewswire-USNewswire/ -- A new service for health care providers prescribing methadone to treat chronic pain or opioid addiction -- the Physician Clinical Support System for Methadone (PCCS-M) -- opens this week with a mechanism to connect prescribers of methadone with experienced clinicians for one-to-one mentoring regarding the use of this medication. Methadone is an inexpensive opioid medication that has several unique properties that make it particularly...

2009-05-18 06:00:00

-Here to Help(TM), a new support program designed to improve treatment outcomes for patients dependent on prescription painkillers or heroin, from Reckitt Benckiser Pharmaceuticals- RICHMOND, Va., May 18 /PRNewswire/ -- Reckitt Benckiser Pharmaceuticals has launched Here to Help(TM), an unique patient support program designed to improve outcomes for people in opioid dependence treatment with SUBOXONE(R) (buprenorphine HCl/naloxone HCl dihydrate [2 mg/0.5 mg and 8 mg/2 mg]) C-III...

2009-04-28 10:41:39

Federal officials say they have started a program designed to ensure the safe use of methadone, a prescription drug used to treat heroin addiction. The U.S. Substance Abuse and Mental Health Services Administration and the U.S. Food and Drug Administration said the campaign responds to concerns about escalating numbers of poisoning deaths linked with improper use of the medication. The program -- Follow Directions: How to Use Methadone Safely -- is designed to inform consumers, health care...

2008-10-21 09:00:54

FARMINGTON, Conn., Oct. 21 /PRNewswire/ -- Launched in September 2006, NAABT.org's (http://www.naabt.org/) free and anonymous online matching system has connected nearly 14,000 addicted patients with physicians certified to prescribe Suboxone for opioid addiction. Less than 2% of US physicians are allowed by law to prescribe this treatment, and those that do have a Congress imposed limit on how many patients they can treat (30 or 100 based on how long they have been certified). Virtually...